One study published before the AT(N) described five subgroups with different biomarker profiles; one of the AD groups was characterized by individuals with high incidence of Lewy bodies, abnormal CSF Aβ42, normal T-tau (P-tau was not addressed) and late onset and older age [41]. The gene discussed is MAPT; the disease is Alzheimer disease.